NeuroOne Medical Technologies Past Earnings Performance
Past criteria checks 0/6
NeuroOne Medical Technologies's earnings have been declining at an average annual rate of -6.2%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 54.2% per year.
Key information
-6.2%
Earnings growth rate
31.6%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 54.2% |
Return on equity | -304.9% |
Net Margin | -478.5% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Dec 16Can NeuroOne Medical Technologies (NASDAQ:NMTC) Afford To Invest In Growth?
Jul 25Here's Why We're Watching NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Situation
Apr 11We Think NeuroOne Medical Technologies (NASDAQ:NMTC) Needs To Drive Business Growth Carefully
Sep 15NeuroOne rallies on receiving $3.5M in accelerated milestone payment from Zimmer Biomet
Aug 03Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Jun 02Companies Like NeuroOne Medical Technologies (NASDAQ:NMTC) Could Be Quite Risky
Dec 18NeuroOne: Thin Film Electrodes For Diagnosis And Treatment Of Neurological Conditions
Nov 19Will NeuroOne Medical Technologies (NASDAQ:NMTC) Spend Its Cash Wisely?
Sep 04We're Not Very Worried About NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Rate
May 27Revenue & Expenses BreakdownBeta
How NeuroOne Medical Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 3 | -13 | 7 | 0 |
30 Sep 23 | 3 | -12 | 7 | 0 |
30 Jun 23 | 5 | -10 | 7 | 0 |
31 Mar 23 | 4 | -9 | 7 | 0 |
31 Dec 22 | 4 | -9 | 7 | 0 |
30 Sep 22 | 2 | -10 | 7 | 0 |
30 Jun 22 | 0 | -11 | 7 | 0 |
31 Mar 22 | 0 | -11 | 7 | 0 |
31 Dec 21 | 0 | -11 | 7 | 0 |
30 Sep 21 | 0 | -10 | 6 | 0 |
30 Jun 21 | 2 | -8 | 6 | 0 |
31 Mar 21 | 2 | -12 | 5 | 0 |
31 Dec 20 | 2 | -11 | 5 | 0 |
30 Sep 20 | 2 | -14 | 5 | 0 |
30 Jun 20 | 0 | -14 | 4 | -1 |
31 Mar 20 | 0 | -9 | 5 | -1 |
31 Dec 19 | 0 | -10 | 5 | 0 |
30 Sep 19 | 0 | -7 | 4 | 0 |
30 Jun 19 | 0 | -8 | 4 | 1 |
31 Mar 19 | 0 | -7 | 4 | 1 |
31 Dec 18 | 0 | -6 | 4 | 1 |
30 Sep 18 | 0 | -7 | 3 | 1 |
30 Jun 18 | 0 | -6 | 3 | 1 |
31 Mar 18 | 0 | -6 | 3 | 1 |
31 Dec 17 | 0 | -5 | 2 | 1 |
30 Sep 17 | 0 | -4 | 2 | 1 |
31 Mar 17 | 0 | -1 | 1 | 0 |
31 Dec 16 | 0 | 0 | 0 | 0 |
Quality Earnings: NMTC is currently unprofitable.
Growing Profit Margin: NMTC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NMTC is unprofitable, and losses have increased over the past 5 years at a rate of 6.2% per year.
Accelerating Growth: Unable to compare NMTC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NMTC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: NMTC has a negative Return on Equity (-304.92%), as it is currently unprofitable.